Claims
- 1. An injectable micro-implantation system for long-term augmentation of soft tissue, comprising in combination:
- biologically compatible micro particles of a relatively resilient, malleable material dispersed in a non-retentive compatible physiological vehicle, the micro particles being further characterized by a rough surface texture having a plurality of surface irregularities forming openings generally at random therein;
- the textured micro particles having an average particle size generally between 30 and 3000 microns with a dimension of the openings formed by the irregularities within the particles being generally in a range between 10 angstroms and 500 microns;
- wherein relative average particle size and average roughness of texture are sufficient in combination to, in an autogenous manner, substantially preclude migration of the particles from an augmentation site, the particles being incorporated in a final implant; and
- wherein the relatively malleable material is poly(dimethylsiloxane) and the physiological vehicle is a hydrogel of polyvinyl pyrrolidone.
- 2. The injectable micro-implantation system of claim 1 wherein the biologically inert micro particles are of a generally uniform configuration.
- 3. The injectable micro-implantation system of claim 1 wherein a range of average particle size is between 60 and 600 microns.
- 4. The injectable micro-implantation system of claim 3 wherein the openings formed by the irregularities within the particles are of an average size between about 10 and about 200 microns.
- 5. The injectable micro-implantation system of claim 4 wherein the micro particles are generally spherical in shape.
- 6. The injectable micro-implantation system of claim 1 wherein:
- a range of average particle size is between 100 microns and 600 microns; and
- wherein the openings formed by the irregularities within the particles are of an average size between about 10 and about 200 microns.
- 7. The injectable micro-implantation system of claim 6 wherein the micro particles are generally spherical in shape.
- 8. The injectable micro-implantation system of claim 1 wherein the average particle size is at least 80 microns.
- 9. The injectable micro-implantation system of claim 8 wherein the openings formed by the irregularities within the particles are of an average size between about 10 and about 200 microns.
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a continuation-in-part of application Ser. No. 07/282,671, filed Dec. 12, 1988, abandoned Aug. 15, 1992.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
4678470 |
Nashef et al. |
Jul 1987 |
|
4863472 |
Tormala et al. |
Sep 1989 |
|
Non-Patent Literature Citations (2)
Entry |
Balazs, et al., "Replacement of the Vitreous with Hyaluronic Acid, Collagen and Other Polymers", Advances in Vitreous Surgery, Chapter 57, pp. 601-603 (1976). |
Balazs, et al., "The Injection of Hyaluronic Acid and Reconstituted Vitreous into the Vitreous Cavity", New and Controversial Aspects of Retinal Detachment, Chapter 36: Hyoluronic Acid and Reconstituted Vitreous, pp. 371-376 (1968). |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
282671 |
Dec 1988 |
|